Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease BEFREE Apolipoprotein B (APOB), and hepatic lipase (LIPC) genes have been shown to play a key role in lipid metabolism in type 2 diabetes (T2D). 29883758 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease GENOMICS_ENGLAND Functional characterization of novel variants in the CETP promoter and the LIPC gene in subjects with hyperalphalipoproteinemia. 23219720 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE The LIPC -250G>A (rs2070895) variant was genotyped in the Inter99 study (n = 6070), the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care Denmark screening cohort of individuals with risk factors for undiagnosed type 2 diabetes (n = 8662), and in additional type 2 diabetic patients (n = 1,064) and glucose-tolerant control subjects (n = 360). 18364377 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.680 AlteredExpression disease BEFREE Elevated hepatic lipase (HL, also known as LIPC) expression is a key factor in the development of the atherogenic lipid profile in type 2 diabetes and insulin resistance. 18758746 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE Patients with type 2 diabetes who are carriers of the rare -250A allele in the promoter of the hepatic lipase gene are susceptible to PAD. 18413186 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE The G-250A promoter polymorphism of the LIPC gene is associated with an increased risk of development of type 2 diabetes in high-risk subjects with IGT. 15656877 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease CTD_human The G-250A promoter polymorphism of the LIPC gene is associated with an increased risk of development of type 2 diabetes in high-risk subjects with IGT. 15656877 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease CTD_human We investigated whether the G-250A polymorphism of the hepatic lipase gene (LIPC) predicts the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the Finnish Diabetes Prevention Study. 15126514 2004
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE We investigated whether the G-250A polymorphism of the hepatic lipase gene (LIPC) predicts the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the Finnish Diabetes Prevention Study. 15126514 2004
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE Little is known about the effect of cholesterol synthesis inhibitors on HL activity in relation to sex and the hepatic lipase gene, the LIPC promoter variant in type 2 diabetes. 12547874 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.680 GeneticVariation disease BEFREE In conclusion, despite the higher frequency of the T allele in Chinese than in Caucasians, gender was the best predictor for HL activity, with LIPC gene polymorphism and type 2 diabetes making relatively smaller contributions to the variation in HL activity. 11427226 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease GENOMICS_ENGLAND
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease GENOMICS_ENGLAND
Diabetes Mellitus, Non-Insulin-Dependent
0.680 Biomarker disease HPO
Diabetes Mellitus, Non-Insulin-Dependent
0.680 SusceptibilityMutation disease CLINVAR